Osteoporosis drugs may boost cancer risk
People who take bisphosphonates, or bone-strengthening drugs for osteoporosis, may have a slightly higher risk of developing esophageal cancer, especially if they take them for several years, a study out this week in the British Journal of Medicine finds.
Researchers tracked almost 3,000 people with cancer of the esophagus or throat for eight years and compared them with a group of 15,000 people who did not have the disease. All were over age 40. The scientists found that 90 of the cancer patients had been prescribed the bone-building drugs, while 345 people in the larger group were taking the medication.
By figuring the odds, scientists estimated the risk of esophageal cancer increased with 10 or more prescriptions for oral bisphosphonates or with prescriptions over a five-year period. According to the study, in Europe and North America, the incidence of esophageal cancer in people ages 60-79 is typically one per every 1,000 over five years. This study estimated an increase of two per 1,000 in this age group, if the drugs were used for five years or more.
The researchers also looked at about 10,000 people with bowel cancer and 2,000 others with stomach cancer and found no increased risk with the use of these drugs…
Experts aren’t sure why the drugs might lead to throat cancer. They do know however, that bisphosphonates can cause inflammation in the esophagus, which could cause cancer to develop more easily.
Related posts:
Osteoporosis and red clover, red clover is a source of many valuable nutrients including calcium, chromium, magnesium, niacin, phosphorus, potassium, thiamine, and vitamin C. Red clover is also considered to be one of the richest sources of isoflavones water-soluble chemicals that act like estrogens and are found in many plants. Several studies of a proprietary extract of red clover isoflavones suggest that it may significantly reduce hot flashes in menopausal women. Also, menopause increases a woman’s risk for developing osteoporosis significant bone loss and some studies suggest that a proprietary extract of red clover isoflavones may slow bone loss and even boost bone mineral density in pre and peri-menopausal women. The estrogen-like effect of red clover isoflavones may be involved, and red clover also may have a direct effect by preventing the breakdown of existing bone. However, this possible bone-strengthening effect has not been seen in men and post-menopausal women. Because it contains chemicals called isoflavones, which belong to a larger class of plant chemicals known as phyto (plant-derived) estrogens, red clover is often taken to relieve symptoms of premenstrual syndrome (PMS). Isoflavones are similar in shape to the female hormone, estrogen. Therefore, they may attach to estrogen receptors throughout the body particularly in the bladder, blood vessels, bones, and heart.